PULM NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Pulmatrix Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 1.74 USD
5.5% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -5.1% below the Trend Line and sits at 13.1% of its 52-week range. The latest completed week returned 5.5%, after a 1.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 27 out of 100
Latest Close 1.74 USD 31 Jul 2026
1W Return 5.5% latest completed week
4W Return 1.2% short-term follow-through
12W Return 34.1% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 43.55% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 5.5% Latest completed week; four-week move 1.2%. Indicator stack 0/69 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.55% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 46 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -5.1% below the Trend Line and sits at 13.1% of its 52-week range. The latest completed week returned 5.5%, after a 1.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1912-week average 0.08

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.19Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.2% over four weeks, 34.1% over 12 weeks, and -67.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W5.5%
4W1.2%
12W34.1%
26W-32.3%
52W-67.4%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.04Latest activity-pressure read.
Pressure change8.6%Four-week change in activity pressure.
Leadership-47.14Latest relative-leadership reading.
RS change14.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 64% Model confidence 61%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength42/100Blend of value, momentum, and quality. Underlying universe rank 59; rank 1 is best.
Value46/100Relative valuation strength. Underlying universe rank 55; rank 1 is best.
Quality45/100Profitability and accounting quality. Underlying universe rank 56; rank 1 is best.
Momentum46/100Medium-term price momentum. Underlying universe rank 55; rank 1 is best.
Growth47/100Revenue and earnings growth. Underlying universe rank 54; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-128.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 46 relevant articles.

6 positive · 35 neutral · 5 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-68.8%Distance below the 52-week high.
13-week volatility4.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2611 weeks finished lower.
Best week+18.0%Week of 20 Mar.
Worst week-45.4%Week of 27 Mar.
Latest week+5.5%Week of 31 Jul.

Shape of recent returns

Strong gains12
Modest gains2
Flat weeks1
Modest losses6
Sharp losses5
Recent vol4.7%13-week weekly-return volatility.
Base vol11.9%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew6.0% / -8.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape19/100

Trend, activity pressure, participation, and risk combine to a 19/100 tape read.

 Indicator analysis26/100

Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.

Activity pressure 0.19; No reversal markers Next-Week ExpectancyNegative 43.55%

Next-week expectancy is negative with a 43.55% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors44/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 51 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment50/100

Weighted news tone is neutral across 46 relevant articles.

PULM|Pulmatrix Inc|Price:1.700|Chg%:+0.030 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.74 USD5.5%1.83 USD3.49 USD1.04-47.1467.2KOff
24 Jul 20261.65 USD-2.4%1.85 USD3.50 USD1.08-51.0055.9KOff
17 Jul 20261.69 USD-1.7%1.87 USD3.50 USD1.02-52.0387.3KOff
10 Jul 20261.72 USD0.0%1.90 USD3.51 USD1.06-54.70193.5KOff
3 Jul 20261.72 USD4.9%1.99 USD3.51 USD0.96-55.3793.3KOff
26 Jun 20261.64 USD12.3%2.07 USD3.52 USD0.66-58.46433.3KOff
19 Jun 20261.46 USD4.3%2.16 USD3.53 USD0.45-65.911.5MOff
12 Jun 20261.40 USD5.3%2.27 USD3.54 USD0.16-67.75227.0KOff
5 Jun 20261.33 USD-4.3%2.38 USD3.54 USD-0.14-69.90111.1KOff
29 May 20261.39 USD3.7%2.50 USD3.55 USD-0.25-71.2766.1KOff
22 May 20261.34 USD7.2%2.62 USD3.56 USD-0.37-72.7498.3KOff
15 May 20261.25 USD-3.6%2.73 USD3.57 USD-0.46-75.0783.6KOff
8 May 20261.30 USD0.6%2.85 USD3.58 USD-0.47-74.9587.4KOff
1 May 20261.29 USD-4.4%2.97 USD3.59 USD-0.45-74.45100.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.